Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.9K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

676
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
676
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

492
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
492
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

455
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
455
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

617
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
617
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

4.1K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
4.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Large-Scale Collaborative Assessment of Binding Free Energy Calculations for Drug Discovery Using OpenFE.

Journal of chemical information and modeling·2026
Same author

An Automated Workflow for Diagnosing Sampling Issues Caused by Slow Torsional Motions in Molecular Simulations.

Journal of chemical information and modeling·2026
Same author

Efficient Binding Affinity Estimation for Fragment-Based Compounds Using a Separated Topologies Approach.

Journal of chemical information and modeling·2026
Same author

The Open Molecular Software Foundation (OMSF) and the Growing Role of Open Source Software in Molecular Modeling.

Journal of chemical information and modeling·2026
Same author

A Quadrupolar Fullerene Model System for Benchmarking Enhanced Sampling of Trapped Waters in Free Energy Calculations.

The journal of physical chemistry. B·2026
Same author

Structure-Based Experimental Datasets for Benchmarking Protein Simulation Force Fields [Article v1.0].

Living journal of computational molecular science·2026
Same journal

Journal research data policies in materials science.

Digital discovery·2026
Same journal

Text-to-flowsheet: an LLM-assisted pipeline for expert-level digitization and automated simulation of chemical processes.

Digital discovery·2026
Same journal

<i>optimade-maker</i>: automated generation of interoperable materials APIs from static datasets.

Digital discovery·2026
Same journal

RobInHood: a robotic chemist in a fume hood.

Digital discovery·2026
Same journal

Molecular arms race classifier for decrypting venom peptide and ion channel interactions.

Digital discovery·2026
Same journal

Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models.

Digital discovery·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 13, 2026

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
10:16

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

46.9K

マルチターゲットの結合を考慮して薬物発見のための単純な化合物優先順位付け方法.

Alžbeta Kubincová1, David L Mobley1

  • 1Department of Pharmaceutical Sciences, University of California Irvine Irvine CA 92697 USA dmobley@uci.edu.

Digital discovery
|February 12, 2026
PubMed
まとめ
この要約は機械生成です。

この研究は,薬物発見のための多目的のアクティブ・ラーニング・メソッドを導入しています. 複数の分子特性を同時に効率的に最適化し,望ましい特性を有する薬剤候補者の識別を改善します.

さらに関連する動画

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.6K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.3K

関連する実験動画

Last Updated: Feb 13, 2026

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
10:16

Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets

Published on: March 12, 2019

46.9K
A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.6K
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

14.3K

科学分野:

  • 計算化学はコンピュータ化学である.
  • 薬剤化学 薬剤化学について
  • ドラッグ・ディスカバリー・ドラッグ・ディスカバリー

背景:

  • アクティブ・ラーニングは,分子特性を最適化することで,薬剤発見を加速します.
  • 以前の方法は,単一のプロパティの最適化に焦点を当て,薬剤候補の有用性を制限していました.
  • 様々な標的への結合親和性などの複数の性質は,薬物開発において極めて重要です.

研究 の 目的:

  • リガンド最適化のための多目的のアクティブ・ラーニング・メソッドの開発と検証.
  • 多重で計算上高価な分子特性を効率的に処理するために.
  • 医薬品研究におけるヒット・トゥ・リードとリード最適化の効率を向上させる.

主な方法:

  • 新しい多目的リガンド最適化プロトコルを導入しました.
  • 異なる分子特性を同時に最適化するために,アクティブ・ラーニングを応用した.
  • ドッキングスコアを使用して,方法を遡って検証しました.

主要な成果:

  • 貪欲な取得と比較して,トップの薬物結合物質の改善された回収を達成しました.
  • 多重で計算が難しい分子特性の効率的な処理が実証されています.
  • 個々のプロパティを別々にフィッティングすることで,予測ランク相関性が向上することが示されました.

結論:

  • 多目的のアクティブ・ラーニングアプローチは,薬剤発見の効率を高めます.
  • この方法は,複数の重要な性質の計算予算を効果的にバランスします.
  • ワークフローは,複数のターゲットの化合物を最適化することによって,医薬品研究をサポートします.